Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2015 Jul 23;2(4):e136.
doi: 10.1212/NXI.0000000000000136. eCollection 2015 Aug.

Sleep disorder, chorea, and dementia associated with IgLON5 antibodies

Mateus M Simabukuro  1 , Lidia Sabater  1 , Tarso Adoni  1 , Rubens Gisbert Cury  1 , Mônica Santoro Haddad  1 , Camila Hobi Moreira  1 , Luana Oliveira  1 , Mateus Boaventura  1 , Rosana Cardoso Alves  1 , Leticia Azevedo Soster  1 , Ricardo Nitrini  1 , Carles Gaig  1 , Joan Santamaria  1 , Josep Dalmau  1 , Francesc Graus  1
Affiliations

Sleep disorder, chorea, and dementia associated with IgLON5 antibodies

Mateus M Simabukuro et al. Neurol Neuroimmunol Neuroinflamm. .
No abstract available

PubMed Disclaimer

References

    1. Högl B, Heidbreder A, Santamaria J, Graus F, Poewe W. IgLON5 autoimmunity and abnormal behaviours during sleep. Lancet 2015;385:1590. - PubMed
    1. Sabater L, Gaig C, Gelpi E, et al. A novel non-rapid-eye movement and rapid-eye-movement parasomnia with sleep breathing disorder associated with antibodies to IgLON5: a case series, characterisation of the antigen, and post-mortem study. Lancet Neurol 2014;13:575–586. - PMC - PubMed
    1. Lugaresi E, Provini F. Agrypnia excitata: clinical features and pathophysiological implications. Sleep Med Rev 2001;5:313–332. - PubMed
    1. Gaig C, Iranzo A, Santamarí J, Dalmau J, Graus F. Sleep disorder associated with antibodies to IgLON5: parasomnia or agrypnia?—Authors' reply. Lancet Neurol 2014;13:864–865. - PubMed
    1. Spillantini MG, Goedert M. Tau pathology and neurodegeneration. Lancet Neurol 2013;12:609–622. - PubMed